Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 8/2021

01-08-2021 | Ovarian Cancer | Correction

Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario

Authors: Jordan Lerner-Ellis, Chloe Mighton, Conxi Lazaro, Nicholas Watkins, Vanessa Di Gioacchino, Andrew Wong, Martin C. Chang, George S. Charames

Published in: Journal of Cancer Research and Clinical Oncology | Issue 8/2021

Login to get access

Excerpt

In the original article published, the proportions for the categories "Non-AJ, non-FC, non-Hispanic White" and "Other ethnicity" have incorrectly been reversed. The correct values for "Non-AJ, non-FC, non-Hispanic White" should be 62.3% (2024) and "Other ethnicity" should be 4.2% (136). …
Metadata
Title
Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
Authors
Jordan Lerner-Ellis
Chloe Mighton
Conxi Lazaro
Nicholas Watkins
Vanessa Di Gioacchino
Andrew Wong
Martin C. Chang
George S. Charames
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 8/2021
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03399-0

Other articles of this Issue 8/2021

Journal of Cancer Research and Clinical Oncology 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.